Collegium Pharmaceutical, Inc. COLL Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s accrued expenses?
- Collegium Pharmaceutical, Inc. (COLL) reported accrued expenses of $3.61M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s accrued expenses changed year-over-year?
- Collegium Pharmaceutical, Inc.'s accrued expenses decreased by 93.3% year-over-year, from $53.74M to $3.61M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s accrued expenses has grown at a -32.8% compound annual growth rate (CAGR), from $24.66M to $3.38M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.